Skip to main content

News

By Rachel McArthur | 05:04 am | January 21, 2021
Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them.
By Rachel McArthur | 05:03 am | January 21, 2021
There are four main types of vaccines currently approved, in approval or being considered in the MENA region in its fight against COVID-19. We bring you a summary of just what they are, how they differ, along with the advantages and disadvantages of each type.
By Dean Koh | 02:19 am | January 21, 2021
The center operates on a 24 x 7 basis, and patients can either call in, email or reach out through social media platforms.
By Mike Miliard | 03:59 pm | January 20, 2021
The use of realistic health record information that mimics lifelong medical histories can enable more innovative algorithms for disease modeling.
By Kat Jercich | 03:57 pm | January 20, 2021
"Telehealth matters," reads the synopsis of the new bill, which also has provisions prohibiting Medicaid from specifying originating and distant sites for reimbursement purposes.
By Kat Jercich | 01:49 pm | January 20, 2021
The company had donated to the 2020 campaigns of a dozen federal legislators who went on to object to the presidential election results.
By Mike Miliard | 12:01 pm | January 20, 2021
The update to its COVID Community Vulnerability Map uses artificial intelligence to help guide vaccine distribution to patient populations most at risk.
By Bill Siwicki | 10:06 am | January 20, 2021
Bee Busy Wellness Center is using a $183,000 FCC grant to add an array of hardware and infrastructure that will take its telemedicine to the next level.
By Sophie Porter | 03:15 am | January 20, 2021
NHSX develops national imaging database to identify patterns and variations of COVID-19 in UK patients..